SIELECKI-DZURDZ; Thais Motria
Patent Applications and Registrations
Patent applications and USPTO patent grants for SIELECKI-DZURDZ; Thais Motria.The latest application filed is for "method for synthesizing d3 dopamine receptor agonists".
- SIELECKI-DZURDZ; Thais Motria - Kennett Square PA
- Sielecki-Dzurdz; Thais Motria - Newark DE
| Patent | Date |
|---|---|
| Method For Synthesizing D3 Dopamine Receptor Agonists App 20220009876 - SIELECKI-DZURDZ; Thais Motria ; et al. | 2022-01-13 |
| Pyridino and pyrimidino pyrazinones Grant 7,067,658 - Sielecki-Dzurdz , et al. June 27, 2 | 2006-06-27 |
| Pyridino and pyrimidino pyrazinones App 20040082784 - Sielecki-Dzurdz, Thais Motria ; et al. | 2004-04-29 |
| Isoxazoline and isoxazole fibrogen receptor antagonists Grant 6,114,328 - Wityak , et al. September 5, 2 | 2000-09-05 |
| Isoxazoline and isoxazole fibrinogen receptor antagonists Grant 5,849,736 - Wityak , et al. December 15, 1 | 1998-12-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 